Cytokine genotyping in preeclampsia

American Journal of Reproductive Immunology

Volumn 55, Issue 2, 2006, Pages 130-135

  Daher, Silvia ^a,b   Sass, Nelson ^a   Oliveira, Leandro G ^a   Mattar, Rosiane ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Cytokine; Gene polymorphism; Preeclampsia

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CAUCASIAN; CHI SQUARE TEST; CONTROLLED STUDY; CYTOKINE PRODUCTION; DATA ANALYSIS; DNA POLYMORPHISM; FEMALE; FISHER EXACT TEST; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; META-ANALYSIS; MIDDLE AGED; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY;

EID: 33644683965     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2005.00341.x     Document Type: Article

References (21)

1. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD: Williams Obstetric, 21st edn. New York, McGraw-Hill Medical Publishing Division, 2001.
2. Darmochwal-Kolarz D, Leszcynska-Gorzelak B, Rolinski J, Oleszcuk J: T helper 1- and T helper 2-type cytokine imbalance in pregnant women with preeclampsia. Eur J Obst Gynecol Reprod Biol 1999; 86: 165-170.
3. Daher S, Denardi KAG, Blotta MHSL, Mamoni RL, Reck APM, Camano L, Mattar R: Cytokines in recurrent pregnancy loss. J Reprod Immunol 2004; 62: 151-157.
4. Huber A, Hefler L, Tempfer C, Zeisler H, Lebrecht A, Husslein P: Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 2002; 81: 168-171.
5. Shaarawy M, El Meleigy M, Rasheed K: Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome. J Soc Gynecol Investig 2001; 8: 27-31.
6. Bidwell J, Keen L, Gallagher G, Kimberley R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S: Cytokine gene polymorphism in human disease: On line databases. Genes Immun 2001; 1: 3-19.
7. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, Mckillop JH: Tumour necrosis factor-alpha (TNF- α) gene polymorphism and expression in preeclampsia. Clin Exp Immunol 1996; 104: 154-159.
8. Dizon-Townson DS, Major H, Ward K: A promoter mutation in the tumor necrosis factor α gene is not associated with preeclampsia. J Reprod Immunol 1998; 38: 55-61.
9. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA: Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 43: 708-714.
10. Kaiser T, Grehan M, Brennecke SP, Moses EK: Association of the TNF2 allele with eclampsia. Gynecol Obstet Invest 2004; 57: 204-209.
11. Saarela T, Hiltunen M, Helisalmi S, Heinonen S, Laakso M: Tumor necrosis factor-α gene haplotype is associated with pre-eclampsia. Mol Hum Reprod 2005; 18: 1-4.
12. Livingston JC, Park V, Barton JR, Elfering S, Haddad B, Mabie WC, Quasney M, Sibai BM: Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor α and lymphotoxin α genes and plasma tumor necrosis factor α levels. Am J Obstet Gynecol 2001; 184: 1273-1277.
13. Rein DT, Breindenbach M, Honscheid B, Friebe-Hoffman U, Engel H, Gohring UJ, Uekermann L, Kurbacher CM, Schondorf T: Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. Cytokine 2003; 23: 119-125.
14. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr, Bennet WA: Expression of the placental cytokines tumor necrosis factor [alpha], interleukin 1[beta], and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181: 915-920.
15. de Groot CJ, Jansen MW, Bertina RM, Schonkeren JJ, Helmerhorst FM, Huizinga TW: Interleukin 10-2849AA genotype protects against pre-eclampsia. Genes Immun 2004; 5: 313-314.
16. Hassan MI, Aschner Y, Manning CH, Xu J, Aschner JL: Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. Cytokine 2003; 21: 10-16.
17. Warle MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, Zondervan PE, Kap M et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003; 9: 170-181.
18. Hoffmann SC et al: Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28 stimulated peripheral blood lymphocytes. Transplantation 2001; 72: 1444-1450.
19. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV: In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene. Eur J Immunogenet 1999; 26: 1-3.
20. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
21. Wilson AG, De Vries N, Pociot F, di Giovine FS, van der Putte LB, Doff GW: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993; 177: 557-560.